BSX
CALLS ▲Boston Scientific Corporation
$46.73
+1.59%delayed
News – · Trend ▲ · above call trigger ▲
Expected move (1d)
▼ $44.99to$48.47 ▲
ATR ±$1.74 (+3.72%)Implied ±$1.90 (+4.07%)
Entry Reference
Price / prev close$46.73 / $46.00
Day range$44.43 – $46.80
52-wk range$42.20 – $109.50(7%)
Volume vs avg0.89×
ATR (14d)$1.74
MA 8 / 21$45.14 / $44.60
MA 50 / 200$46.61 / $73.17
Call ▲ / Put ▼ trigger$46.41 / $45.59
+1 / +2 ATR$48.47 / $50.21
-1 / -2 ATR$44.99 / $43.25
Support: 46.37 42.50 42.20
Resistance: 47.17 50.14 52.52
Near-the-money contracts
exp 2026-08-07Calls
| Strike | Mark | IV | Δ | θ/day | OI |
|---|---|---|---|---|---|
| 44.5 | $2.47 | 56% | 0.77 | -0.09 | 130 |
| 45 | $2.20 | 52% | 0.74 | -0.09 | 875 |
| 46 | $1.52 | 49% | 0.62 | -0.10 | 460 |
| 47 | $0.95 | 46% | 0.48 | -0.10 | 169 |
| 48 | $0.55 | 45% | 0.33 | -0.09 | 133 |
| 48.5 | $0.42 | 45% | 0.27 | -0.08 | 44 |
Puts
| Strike | Mark | IV | Δ | θ/day | OI |
|---|---|---|---|---|---|
| 45 | $0.42 | 46% | -0.24 | -0.07 | 506 |
| 46 | $0.75 | 46% | -0.38 | -0.09 | 49 |
| 46.5 | $0.95 | 45% | -0.45 | -0.09 | 30 |
| 47 | $1.20 | 45% | -0.52 | -0.09 | 60 |
| 47.5 | $1.50 | 47% | -0.59 | -0.09 | 116 |
| 48 | $1.82 | 46% | -0.66 | -0.08 | 12 |
Δ = delta (≈ probability ITM), θ/day = daily time decay, IV = implied vol. Greeks computed via Black-Scholes from Yahoo IV.
Recent news
- BSX Q2 Deep Dive: WATCHMAN and Electrophysiology Challenges Temper Growth Outlook10h ago
- Argus Research Downgrades Boston Scientific (BSX)14h ago
- Roblox downgraded, Quanta Services upgraded: Wall Street's top analyst calls1d ago
- Here Are Friday’s Top Wall Street Analyst Research Calls: Blackstone Mortgage, Boston Scientific, Edison International, Ford, GoDaddy, International Paper, Roblox, Saia, and More2d ago
- Argus Research Downgrades Boston Scientific to Hold2d ago
- Penumbra, Inc. Reports Second Quarter 2026 Financial Results2d ago
- UBS Maintains Buy on Boston Scientific, Lowers Price Target to $672d ago
- Boston Scientific Lowered Full-Year Guidance on Headwinds in Electrophysiology, Watchman Portfolios, RBC Says2d ago
- Citigroup Maintains Buy on Boston Scientific, Lowers Price Target to $612d ago
- BSX Q2 Earnings Call Highlights WATCHMAN and EP Pressure2d ago
- RBC Capital Maintains Outperform on Boston Scientific, Lowers Price Target to $702d ago
- TD Cowen Maintains Buy on Boston Scientific, Lowers Price Target to $563d ago
Reference data only. Not a recommendation. Greeks and expected-move figures are estimates, not certainties. You confirm all entries and contracts in TradingView and Charles Schwab.